EGEIRO Pharma (XPAR:ALVET) Other Stockholders Equity : €1.72 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is EGEIRO Pharma Other Stockholders Equity?

EGEIRO Pharma's Other Stockholders Equity for the quarter that ended in Dec. 2023 was €1.72 Mil.

EGEIRO Pharma's quarterly Other Stockholders Equity declined from Dec. 2022 (€1.62 Mil) to Jun. 2023 (€1.61 Mil) but then increased from Jun. 2023 (€1.61 Mil) to Dec. 2023 (€1.72 Mil).

EGEIRO Pharma's annual Other Stockholders Equity increased from Dec. 2021 (€1.43 Mil) to Dec. 2022 (€1.62 Mil) and increased from Dec. 2022 (€1.62 Mil) to Dec. 2023 (€1.72 Mil).

EGEIRO Pharma Other Stockholders Equity Historical Data

The historical data trend for EGEIRO Pharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGEIRO Pharma Other Stockholders Equity Chart

EGEIRO Pharma Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

0.53

0.89

1.43

1.62

1.72

EGEIRO Pharma Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Stockholders Equity	Get a 7-Day Free Trial					1.66	1.62	1.61	1.72	-

EGEIRO Pharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

EGEIRO Pharma Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of EGEIRO Pharma's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

EGEIRO Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EGEIRO Pharma (XPAR:ALVET) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Avenue Jean Mermoz 32/1, Gosselies, BEL, 6041

Website

https://www.egeiro.be

EGEIRO Pharma is a biopharmaceutical company. The company is focused on the clinical development of drugs for Idiopathic Pulmonary Fibrosis, a chronic, devastating, and fatal disease characterized by the deterioration of lung function.

EGEIRO Pharma Headlines

No Headlines